MCL1 and breast cancer: Thus resistance to induction of cell death by BCL-2 targeting, is regularly, albeit not systematically, found across freshly excised luminal breast cancers and expression data are consistent with the notion that the BCL-2 dependency of an individual tumor is mitigated, at least in part, by the contribution of the stroma to MCL-1 expression.